New techniques and technologies are constantly being introduced that deepen our understanding of disease and therapeutic pathways. Biochemical screening methods have long been used in drug discovery labs, and more recently also in academic settings. Recent advances in both imaging technology and high throughput automation have led to the development of high-content screening (HCS) and integrated liquid handling systems that have broad application in academia and industry. These advances in image acquisition and automation have transformed numerous fields and have yielded increased data capture and throughput. This webinar will discuss how integrated HCS imaging systems that have been coupled with novel computer modeling are being applied to systems biology, translational cancer research, and personalized medicine.
During the webinar, our panelists will:
- Provide an overview of available integrated HCS technologies
- Discuss the use of machine learning models (deep learning) in cancer research
- Describe new approaches in personalized cancer research based on HCS
- Answer questions from webinar viewers live and in real time!
The webinar will last approximately 60 minutes.
To learn more about products or technologies related to this webinar, go to: www.perkinelmer.com/genomics